Cibc World Markets Corp Agios Pharmaceuticals, Inc. Transaction History
Cibc World Markets Corp
- $14.8 Billion
- Q2 2025
A detailed history of Cibc World Markets Corp transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 6,959 shares of AGIO stock, worth $279,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,959
Previous 12,541
44.51%
Holding current value
$279,264
Previous $367,000
37.06%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
242Shares Held
61.8MCall Options Held
297KPut Options Held
235K-
Farallon Capital Management LLC San Francisco, CA5.77MShares$231 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$228 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$195 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$144 Million2.72% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.33MShares$93.4 Million0.65% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.2B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...